Lyme disease vaccine produces substantial immune response in clinical trials
An investigational Lyme disease vaccine co-developed by researchers at Stony Brook University, Brookhaven National Laboratory, and at Baxter International Inc. has shown promising safety and efficacy in phase 1/2 More...